Synonyms: Factive® | LB20304 | SB 265805
gemifloxacin is an approved drug (FDA (2003))
Compound class:
Synthetic organic
Comment: Gemifloxacin is a fluoroquinolone antibacterial compound with potent activity against both Gram-negative and Gram-positive microorganisms [2-3].
|
|
Bioactivity Comments |
Gemifloxacin has potent in vitro activity against both Gram-positive and Gram-negative bacteria including; methicillin-susceptible Staphylococcus aureus (MSSA, MIC ≤0.008 μg/mL), methicillin-resistant S. aureus (MRSA, MIC 4 μg/mL), methicillin-susceptible Staphylococcus epidermidis (MSSE, MIC 0.008 μg/mL), methicillin-resistant S. epidermidis 178 (MRSE, MIC 4 μg/mL), Pseudomonas aeruginosa (MIC 0.25 μg/mL), and Enterobacteriaceae (MIC ≤0.008-0.031 μg/mL) [2]. |